Holen Sie sich die Stockscreener-App
16.23
0.19%
0.05
Handel nachbörslich:
16.21
-0.02
-0.12%
Schlusskurs vom Vortag:
$16.18
Offen:
$16.2
24-Stunden-Volumen:
157.53K
Relative Volume:
1.12
Marktkapitalisierung:
$468.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.66%
1M Leistung:
+14.40%
6M Leistung:
+37.14%
1J Leistung:
+8.21%
1-Tages-Spanne:
$16.04
$16.30
1-Wochen-Bereich:
$15.79
$16.30
52-Wochen-Spanne:
$10.55
$16.30
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Firmenname
Abrdn Life Sciences Investors
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie HQL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
16.23 | 461.96M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
10.03 | 3.72B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
41.38 | 3.65B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
22.48 | 2.71B | 0 | 0 | 0 | 0.00 |
|
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
15.68 | 2.46B | 0 | 0 | 0 | 0.00 |
|
GDV
Gabelli Dividend Income Trust
|
26.86 | 2.38B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Aktie (HQL) Neueste Nachrichten
How Abrdn Life Sciences Investors stock performs in rising dollar environmentMarket Trend Review & Real-Time Market Sentiment Reports - newser.com
Earnings visualization tools for Abrdn Life Sciences InvestorsJuly 2025 Volume & Community Consensus Stock Picks - newser.com
Does Abrdn Life Sciences Investors stock trade at a discount to peers2025 AllTime Highs & Daily Volume Surge Trade Alerts - newser.com
Why Abrdn Healthcare Investors stock could benefit from AI revolution2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - newser.com
Can swing trading help recover from Abrdn Life Sciences Investors lossesJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - newser.com
abrdn Life Sciences Investors declares $0.47 dividend - MSN
Abrdn Life Sciences Investors stock prediction for this weekJuly 2025 Highlights & Growth Oriented Trade Recommendations - newser.com
How to escape a deep drawdown in Abrdn Life Sciences Investors2025 Historical Comparison & Risk Controlled Daily Plans - newser.com
Will abrdn Life Sciences Investors Shares stock outperform benchmarksEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Can abrdn Life Sciences Investors Shares stock sustain revenue momentumChart Signals & Free Accurate Trade Setup Notifications - newser.com
Why abrdn Life Sciences Investors Shares stock could be top winnerWeekly Gains Report & Reliable Intraday Trade Plans - newser.com
Will Abrdn Life Sciences Investors stock maintain growth storyJuly 2025 Gainers & Technical Pattern Based Buy Signals - newser.com
Candlestick signals on Abrdn Life Sciences Investors stock todayJuly 2025 Big Picture & Growth-Oriented Investment Plans - newser.com
Published on: 2025-10-05 05:50:21 - newser.com
Can Abrdn Life Sciences Investors stock beat analyst upgrades2025 Key Lessons & Fast Gain Stock Tips - newser.com
abrdn Life Sciences Investors (NYSE:HQL) Sees Significant Drop in Short Interest - MarketBeat
Using data filters to optimize entry into Abrdn Life Sciences Investors2025 Key Highlights & Reliable Price Breakout Signals - newser.com
abrdn Life Sciences Investors (NYSE:HQL) Trading 1.6% HigherHere's What Happened - MarketBeat
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS - Morningstar
What drives Abrdn Life Sciences Investors stock priceIndustrial Stocks Review & Free Rapid Portfolio Appreciation - earlytimes.in
Does Abrdn Healthcare Investors qualify in momentum factor screeningIndex Update & Weekly Top Stock Performers List - newser.com
What analysts say about Abrdn Life Sciences Investors stockPrice Volatility Patterns & Subscribe for Free Weekly Winners - earlytimes.in
Saba Capital Management, L.P. Adjusts Position in abrdn Life Sci - GuruFocus
Historical volatility pattern of Abrdn Healthcare Investors visualizedBull Run & Consistent Return Strategy Ideas - newser.com
Finanzdaten der Abrdn Life Sciences Investors-Aktie (HQL)
Es liegen keine Finanzdaten für Abrdn Life Sciences Investors (HQL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.01%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):